ArticleAnti-cancer agents in medicinal chemistry2026

PRR22: A Novel Prognostic Indicator and Therapeutic Target for Prostate Cancer.

Wenxia Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.